The "Squawk on the Street" news team discuss the latest battle between two big brewers.
CNBC's David Faber reports SABMiller has rejected Anheuser-Busch InBev's latest takeover offer.
Zurich Insurance has terminated its takeover talks with RSA Insurance. Marcus Rivaldi, executive director of credit & equity analytics at Twelve Capital, discusses.
Dara Khosrowshahi, President & CEO, Expedia, discusses synergies after its recently cleared takeover of Orbitz and its brands.
Joe Papa, Perrigo chairman & CEO, talks about Mylan's hostile bid for Perrigo and why he wants shareholders to reject the offer.
Jonny Forsyth, global drinks analyst at Mintel, says SABMiller could provide AB Inbev greater opportunities in different markets.
Anheuser-Busch approached rival SABMiller to explore a tie-up, but no official porposal has been made.
CNBC's Kate Rogers discusses a news report that AMC is in talks to acquire Starz.
Greg Maffei, Liberty Interactive president & CEO discusses his company's $2.4 billion acquisition on Zulily.
The "Squawk Box" news team reports terms of the takeover deal.
Romit Shah, Nomura Securities, discusses Micron's takeover vulnerability, and why SanDisk could be next.
Anthem and Cigna are back in talks, according to sources, reports CNBC's David Faber.
An apparently fake bid for Avon is reportedly being reviewed by the SEC.
Rick Sherlund, Nomura Securities, shares his thoughts on rumors Microsoft may be mulling a potential bid for Salesforce.com, and weighs in on other contenders considering a cloud play.
Samad Samana, FBR Capital Markets, weighs in on potential suitors for Salesforce.com, and big tech's quest to conquer the cloud.
Oracle is the most likely buyer, says Samad Samana, FBR Capital Markets, sharing his thoughts on possible buyers for Salesforce.
Shares of Salesforce.com jumped on Wednesday amid a Bloomberg report that it is working with financial advisors to help with a potential takeover offer. Samad Samana, FBR VP research analyst, weighs in.
Reports say Endo International is making a takeover offer for Salix Pharmaceuticals. CNBC's David Faber has the details.
David Pyott, Allergan chairman & CEO, discusses the company's historic quarter, Bill Ackman's failed attempt to take over the company and the decision to subdivide the management team.
Sunac plans to buy a 49.3 percent stake in troubled Chinese developer Kaisa, which recently missed bond coupon payments, Caixin magazine reported.